Ubs Asset Management Americas Inc Arcellx, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Arcellx, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 264,756 shares of ACLX stock, worth $17.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
264,756
Previous 267,384
0.98%
Holding current value
$17.2 Million
Previous $20.4 Million
14.71%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ACLX
# of Institutions
214Shares Held
48.8MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$293 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$260 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$244 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$229 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$198 Million4.14% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.85B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...